New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
Xencor, Inc.
XNCR
Shape
US Flag

NASDAQ

Unprofitable

Unprofitable

1B

Biotechnology

Next Earning date - 05 Nov 2024

1B

Biotechnology

Next Earning date - 05 Nov 2024

19.46USD
Shape-0.18 ( -0.92%)
favorite-chart

Relative Strenght

29
favorite-chart

Volume Buzz

-48%
favorite-chart

Earning Acce

No
favorite-chart

Dist 52w H.

27%

Quote Panel

Shape
Updated October 3, 2024
1W -3.90 % 1M 17.02 % 3M 6.75 % 1Y 1.25 %

Key Metrics

Shape
  • Market Cap

    1.36B


  • Shares Outstanding

    69.93M


  • Share in Float

    68.04M


  • Dividende

    0


  • Earning Date

    05 Nov 2024


  • Price Target

    19.46


  • Average Volume

    539242


  • Beta

    0.658


  • Range

    15.31-26.84


  • Industry

    Biotechnology


  • Website

    https://www.xencor.com


  • Sector

    Healthcare


Fundamentals

Shape

N/A

P/E Ratio

10.18x

P/S Ratio

2.13x

P/B Ratio

0.0

Debt/Equity

-132.7%

Net Margin

$-2.9

EPS

How XNCR compares to sector?

P/E Ratio

Relative Strength

Shape

XNCR

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$134M

Shape689%

2025-Revenue

$3.20

Shape-199%

2025-EPS

$44M

Shape26%

2025-EBITDA

Analyst rating

No Data Available

Last analyst upgrade/downgrade

Cowen & Co.

initialise

Previous: Not converted

2022-12-06

Now: Outperform

Raymond James

upgrade

Previous: Not converted

2022-10-13

Now: Strong Buy

Earnings GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

N/A

-0.55
vs -0.69

Q4.22

arrow
arrow

N/A

-0.20
vs 1.21

Q1.23

arrow
arrow

N/A

-1.02
vs 0.39

Q2.23

arrow
arrow

N/A

-0.37
vs -0.57

Q3.23

arrow
arrow

N/A

-0.40
vs -0.55

Q4.23

arrow
arrow

N/A

-0.31
vs -0.20

Q1.24

arrow
arrow

N/A

-1.11
vs -1.02

Q2.24

arrow
arrow

N/A

-1.07
vs -0.37

Q3.24

arrow
arrow

N/A

-1.00
vs -0.40

Q4.24

arrow
arrow

N/A

-0.80
vs -0.31

Sales GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

+39%

27.3M  vs 19.7M

Q4.22

arrow
arrow

-86%

21.6M  vs 154M

Q1.23

arrow
arrow

-78%

19M  vs 85.5M

Q2.23

arrow
arrow

+51%

45.5M  vs 30.2M

Q3.23

arrow
arrow

+117%

59.2M  vs 27.3M

Q4.23

arrow
arrow

+107%

44.7M  vs 21.6M

Q1.24

arrow
arrow

-32%

12.8M  vs 19M

Q2.24

arrow
arrow

-63%

17M  vs 45.5M

Q3.24

arrow
arrow

-75%

14.6M  vs 59.2M

Q4.24

arrow
arrow

-45%

24.4M  vs 44.7M

Return on EquityShape

status-upQoQ

Q3.22

arrow
arrow

-5%

-0.05
vs -0.05

Q4.22

arrow
arrow

-2%

-0.02
vs -0.05

Q1.23

arrow
arrow

-9%

-0.09
vs -0.02

Q2.23

arrow
arrow

-3%

-0.03
vs -0.09

Q3.23

arrow
arrow

-4%

-0.04
vs -0.03

Q4.23

arrow
arrow

-3%

-0.03
vs -0.04

Q1.24

arrow
arrow

-11%

-0.11
vs -0.03

Q2.24

arrow
arrow

-12%

-0.12
vs -0.11

Institutionnal OwnershipShape

status-upQoQ

Q3.22

arrow
arrow

176

176
vs 167

5%

Q4.22

arrow
arrow

195

195
vs 176

11%

Q1.23

arrow
arrow

188

188
vs 195

-4%

Q2.23

arrow
arrow

181

181
vs 188

-4%

Q3.23

arrow
arrow

174

174
vs 181

-4%

Q4.23

arrow
arrow

194

194
vs 174

11%

Q1.24

arrow
arrow

202

202
vs 194

4%

Q2.24

arrow
arrow

197

197
vs 202

-2%

Earnings Growth

Latest News